SAN JOSE, Calif., Oct. 24, 2017 -- Restoration Robotics, Inc. (NASDAQ:HAIR), announced today that it will highlight the ARTAS™ Robotic Hair Transplant System (the “ARTAS System”) at two upcoming global medical meetings.
The first meeting is The Dermatologic & Aesthetic Surgery International League (DASIL) 6th World Congress, which will be held in Shanghai, China from October 24-28, 2017. The clinical efficacy, physician and patient experience with the ARTAS System will be shared in a symposium on Wednesday, October 25, 2017, from 12:30 – 1:30 pm local time. DASIL is a non-profit professional organization, founded for the global advancement of knowledge in dermatologic and aesthetic surgery. It includes members from more than 30 countries and spans several medical specialties. It partners with the American Society for Dermatologic Surgery (ASDS) in its international teaching and mentorship programs. Over 1,000 registrants are expected to attend the 6th World Congress. The Restoration Robotics team will be available to meet with healthcare professionals interested in the ARTAS Robotic Hair Restoration System at Booth #F7-8 at the DASIL Congress.
The second meeting is the 2017 Annual Meeting of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), which will be held in Phoenix, AZ from October 26-28, 2017. AAFPRS is the world's largest specialty association for facial plastic surgery. It represents more than 2,700 facial plastic and reconstructive surgeons throughout the world. AAFPRS members are board certified surgeons whose focus is surgery of the face, head, and neck. The Restoration Robotics team will be available to meet with healthcare professionals interested in the ARTAS Robotic Hair Restoration System at Booth #516 at the AAFPRS annual meeting.
Ryan Rhodes, President and Chief Executive Officer of Restoration Robotics, said, “The DASIL Congress and AAFPRS Annual Meeting will give us the opportunity to increase awareness of the ARTAS System to potential customers treating patients for hair restoration from around the world. We look forward to participating in both meetings.”
About Restoration Robotics
Restoration Robotics, Inc., is a medical device company developing and commercializing the ARTAS™ Robotic Hair Restoration System. We believe the ARTAS System is the first and only physician-assisted system to dissect, and assist in the harvesting of, follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. The Company has unique expertise in machine vision, image guidance, visual servoing and robotics, as well as developing intuitive interfaces to manage these technologies.
Media Contact
Lisa Markle
Director of Marketing
Restoration Robotics, Inc.
+1- 408-883-6764
[email protected]
Investor Contact
The Ruth Group
Zack Kubow & Lee Roth
[email protected]
646-536-7000


Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



